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Abstract
Objective: The aims of this study were to investigate the consistency of use of plant
stanol ester margarine and to characterise consistent and inconsistent users.
Design: A cohort of plant stanol ester margarine users was established based on 14
national surveys conducted by the National Public Health Institute in Finland between
1996 and 1999. A follow-up study questionnaire was developed and sent to 1294 users
in 2000.
Setting: Subjects who reported using plant stanol ester margarine in both the original
survey and the follow-up study were classified as consistent users, and the rest as
inconsistent users.
Subjects: The study population consisted of 1094 subjects aged 18–87 years, 590 men
and 504 women.
Results: There were 357 (33%) consistent and 737 (67%) inconsistent users of plant
stanol ester margarine in the study population. Consistent users were more likely to
be men and to have a higher household income than inconsistent users. Both
consistent and inconsistent users were predominantly middle-aged persons with a
healthy lifestyle and diet as well as a history of cardiovascular disease. Healthfulness
was the main factor affecting bread spread choice among 94% of the consistent users
and 59% of the inconsistent users.
Conclusions: The use of plant stanol ester margarine is more often inconsistent than
consistent. There is nevertheless a relatively large subgroup of long-term users of
plant stanol ester margarine. It is important to examine the health effects especially
among these regular users.
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Functional foods are foods that have been shown to have
beneficial health effects beyond adequate nutritional
effects1. During the past decade, there has been increasing
availability and use of functional food products world-
wide. Hence, there is a need for post-marketing research
and surveillance of functional food use patterns and health
effects2–4.
The plant stanol ester margarine Benecolw (Raisio
Group, Raisio, Finland) is a functional food that effectively
lowers serum total and low-density lipoprotein cholesterol
according to several interventions5,6, and is recommended
by the Finnish Society for Internal Medicine for the
primary and secondary prevention of coronary heart
disease7. A longitudinal study of the plant stanol ester
margarine was launched at the National Public Health
Institute in Finland in 1998 in order to evaluate the so far
unknown potential health effects of long-term use of plant
stanol ester margarine.
Our previous study showed that plant stanol ester
margarine users are often elderly persons, many of whom
have a history of cardiovascular disease8. The aims of this
study were to investigate the consistency of use of plant
stanol ester margarine and to characterise consistent and
inconsistent users. This information is necessary in future
studies of the possible health effects, both beneficial and
adverse, of long-term use of plant stanol ester margarine.
Methods
A cohort of users of plant stanol ester margarine was
established based on 14 national surveys conducted by the
National Public Health Institute in Finland between 1996
and 1999. The main surveys were the annual Finnish Adult
Health Behaviour Surveys9 and the Chronic Disease Risk
Factor Survey (Finrisk)10. In each survey, sampling was
either purely random or stratified random with respect to
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age and geographical area, and subjects completed mailed
questionnaires concerning their health and lifestyle.
Participation rates in the surveys varied from 64 to 79%.
There were 1307 plant stanol ester margarine users aged
15–84 years in the cohort, which was 3.4% of the total
number of respondents who gave non-missing infor-
mation on the bread spread question in the 14 surveys
(n ¼ 38 552). They had been identified using the following
question in the survey questionnaire: ‘What type of fat do
you usually use on bread?’ Choices were no fat at all, low-
fat spread, soft margarine, butter–oil mixture, butter, and
plant stanol ester margarine Benecol. The plant stanol
ester margarine Benecol was the only plant sterol
margarine available to consumers in Finland during the
time the surveys were conducted.
A follow-up study questionnaire was developed in
order to update the information gathered in the original
surveys and to study the consistency of use of the plant
stanol ester margarine. Variables that were updated
covered socio-economic background, health status,
medication, smoking, diet, use of alcohol, height, weight
and physical activity. The same question on bread spread
was used in the follow-up study as in the original survey to
identify users of plant stanol ester margarine with the
addition of the response option ‘plant sterol spread’,
which had recently been launched on the Finnish market.
New dietary questions were developed such as the type
and amount of bread spread used during the past 5 years
and the main factor affecting bread spread choice.
A picture from a portion size picture booklet describing
the amount of spread on bread was also included to
improve the validity of the estimation11. In addition to the
plant sterol margarines, an unripened cheese product with
plant stanol ester was on the Finnish market at that time
and a question concerning its use was thus added to the
questionnaire. The questionnaire was tested among
19 employees of the National Public Health Institute and
40 customers of a store in Helsinki, Finland. Questions
were well answered and not considered too difficult.
Addresses of the subjects were updated through the
Population Register Centre of Finland. Questionnaires
were sent to living users of plant stanol ester margarine
who had a permanent address (n ¼ 1294) in October
2000. Two reminders were sent to non-respondents at
3–4 week intervals. Written consent concerning the use of
questionnaire responses and future linkage of the cohort
to health outcome registers was required.
Overall, 1122 persons responded to the follow-up study
questionnaire (87%). Three subjects declined to give
consent and were excluded. Six subjects, who gave
permission to use questionnaire responses but not registry
data, were included. There were 12 subjects who provided
questionnaire responses but failed to provide consent
despite reminders. They were included in this study
because completing and returning the questionnaire was
considered permission to use the questionnaire data.
Subjects with missing information on the bread spread
question (n ¼ 25) were excluded from the analyses. The
final study population thus consisted of 1094 subjects aged
18–87 years, 590 men and 504 women.
Subjects who reported using plant stanol ester
margarine in both the original survey and the follow-up
study were classified as consistent users. Subjects who
reported using plant stanol ester margarine in the original
survey but not in the follow-up study were classified as
inconsistent users. The time interval between completion
of the original survey questionnaire and the follow-up
study questionnaire ranged from 1.5 to 4.5 years.
Consistent and inconsistent users were compared with
respect to sex, age, socio-economic background, self-
reported health, bread spread use, diet, body mass index
and physical activity. Unadjusted prevalence percentages
were computed. The Chi-square test was applied. Data
management and statistical analysis were performed using
the SAS System (version 6.12)12.
Results
There were 357 (33%) consistent and 737 (67%)
inconsistent users of plant stanol ester margarine in the
study population. Consistent users were more likely to be
men and to have higher household income than users
(Table 1). Both the consistent and the inconsistent users
were predominantly middle-aged (mean age 62 and 61
years, respectively), married and retired citizens with
middle or high education (mean years of education 12 and
11, respectively).
More than half of both consistent and inconsistent users
of plant stanol ester margarine reported having a
cardiovascular disease and having had their blood
cholesterol measured during the past 12 months
(Table 2). Of the consistent users, 78% reported a
diagnosis of high or elevated blood cholesterol, and 83%
of those with high cholesterol had received dietary
counselling for lowering of blood cholesterol, compared
with slightly lower proportions (72% and 78%, respect-
ively) among inconsistent users. More than half (55%) of
both the consistent and inconsistent users perceived their
health as good.
The inconsistent users had changed their bread spread
type from plant stanol ester margarine to low-fat spread
(54%), no fat at all (14%), soft margarine (13%), butter–oil
mixture (10%), plant sterol spread (7%) or butter (2%)
(Table 3). Consistent users used, on average, 24 g of plant
stanol ester margarine on their bread daily, compared with
21 g of bread spread among inconsistent users. Almost all
(98%) consistent users had used plant stanol ester
margarine for at least 2 years, while one-third had used
it for 5 years. Healthfulness was the main factor affecting
bread spread choice among 94% of the consistent users
and 59% of the inconsistent users. Of the consistent users,
23% reported using the unripened cheese product with
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Table 1 Sex, age and socio-economic background among consistent and inconsistent users of plant stanol
ester margarine
Consistent
users
Inconsistent
users Total
Consistent vs.
inconsistent users
n % n % n % x 2 P-value
Sex
Men 225 63 365 50 590 54 18 0.001
Women 132 37 372 50 504 46
Total 357 100 737 100 1094 100
10-year age group
18–24 years 0 0 7 1 7 1 12 0.058
25–34 years 1 0 10 1 11 1
35–44 years 11 3 41 6 52 5
45–54 years 79 22 146 20 225 21
55–64 years 103 29 229 31 332 30
65–74 years 124 35 220 30 344 31
75–87 years 39 11 84 11 123 11
Total 357 100 737 100 1094 100
Education
1–9 years 142 40 283 39 425 40 5.1 0.077
10–12 years 72 21 190 26 262 24
13 years or more 139 39 248 35 387 36
Total 353 100 721 100 1074 100
Marital status
Married, cohabiting 282 79 553 75 835 77 1.8 0.18
Single 75 21 181 25 256 23
Total 357 100 734 100 1091 100
Employment status
Unemployed 9 3 30 4 39 3 1.7 0.42
Employed 138 39 288 40 426 40
Retired 202 58 406 56 608 57
Total 349 100 724 100 1073 100
Household income
Low 96 27 252 36 348 33 17 0.001
Middle 117 34 257 37 374 36
High 136 39 186 27 322 31
Total 349 100 695 100 1044 100
Table 2 Self-reported health among consistent and inconsistent users of plant stanol ester margarine
Consistent
users
Inconsistent
users Total
Consistent vs.
inconsistent users
n % n % n % x 2 P-value
Cardiovascular disease
Yes 195 55 407 55 602 55 0.035 0.85
No or missing 162 45 330 45 492 45
Total 357 100 737 100 1094 100
Blood cholesterol measured during past 12 months
Yes 200 57 380 52 580 54 2.4 0.12
No 149 43 347 48 496 46
Total 349 100 727 100 1076 100
High or elevated blood cholesterol diagnosed ever
Yes 272 78 517 72 789 74 5.0 0.025
No 77 22 206 28 283 26
Total 349 100 723 100 1072 100
Dietary counselling for lowering of blood cholesterol received*
Yes 259 83 465 78 724 79 4.2 0.041
No 52 17 135 22 187 21
Total 311 100 600 100 911 100
Self-perceived health
Good 191 55 400 55 591 55 2.0 0.37
Average 134 38 252 35 386 36
Poor 26 7 69 10 95 9
Total 351 100 721 100 1072 100
* In the case that high blood cholesterol was diagnosed.
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plant stanol ester 6–7 days per week, compared with 12%
of the inconsistent users.
Diet could objectively be regarded as healthy among
most of the consistent (70%) and inconsistent (61%) users
(Table 4). Still higher proportions of consistent (86%) and
inconsistent (82%) users perceived their own diets as
healthy. Both the consistent and inconsistent users
reported to have consumed on average 6 alcoholic units
during the past 7 days, while one-third had not consumed
any alcohol during that time. Body mass index (mean
26 kg m22) and leisure-time physical activity were similar
among consistent and inconsistent users.
Discussion
Plant stanol ester margarine has been a major innovation
in the field of functional foods. The type of dietary fat has a
critical influence on blood lipid levels, and consequently
on cardiovascular risk5,6,13. In addition to studies of
efficacy and safety, post-marketing surveillance studies
provide valuable additional information regarding the use
patterns of functional foods.
According to our study, consistent and inconsistent users
of plant stanol ester margarine share several characteristics.
They are predominantly middle-aged persons with a
healthy lifestyle and diet. Among consistent users, men and
persons with a high household income are relatively more
represented compared with inconsistent users.
By the time of the follow-up study, there were two plant
sterol margarines on the Finnish market: the plant stanol
ester margarine Benecol (60% and 32% fat) and the plant
sterol spread Becel pro.active (35% fat). The plant stanol
ester margarine was introduced to the Finnish market in
November 1995. Plant sterol spread was launched
2 months before the follow-up study questionnaires
were sent. Plant stanol ester margarine and plant sterol
spread are sold as ordinary foods in Finland and their
marketing is regulated by legislation. Both products cost
three to five times more than other margarines. Our study
suggests that price has little influence on bread spread
choice among plant stanol ester margarine users.
People who use plant stanol ester margarine seem to
have problems with blood cholesterol levels and a history
of cardiovascular disease. Therefore, it is likely that they
use plant stanol ester margarine in order to control blood
cholesterol levels through dietary practices. Indeed, the
consistent users in our study overwhelmingly regarded
healthfulness as the main factor affecting bread spread
choice. Most of them had also received dietary counselling
for lowering of blood cholesterol.
Table 3 Bread spread use among consistent and inconsistent users of plant stanol ester margarine
Consistent
users
Inconsistent
users Total
Consistent vs.
inconsistent users
n % n % n % x 2 P-value
Current bread spread choice
No fat at all 0 0 101 14 101 9 1094 0.001
Low-fat spread 0 0 396 54 396 36
Soft margarine 0 0 95 13 95 9
Butter–oil mixture 0 0 74 10 74 7
Butter 0 0 19 2 19 2
Plant stanol ester margarine 357 100 0 0 357 32
Plant sterol spread 0 0 52 7 52 5
Total 357 100 737 100 1094 100
Daily amount of spread on bread (g)*
, 20 148 43 403 57 551 52 18 0.001
20–25 84 24 124 17 208 20
. 25 113 33 182 26 295 28
Total 345 100 709 100 1054 100
Duration of plant stanol ester margarine use (years)†
1 4 2 64 37 68 14 144 0.001
2 67 22 52 30 119 25
3 95 32 35 21 130 28
4 34 11 9 5 43 9
5 100 33 11 7 111 24
Total 300 100 171 100 471 100
Main factor affecting bread spread choice
Price 1 0 29 4 30 3 146 0.001
Taste 9 3 144 20 153 15
Healthfulness 327 94 416 59 743 71
Availability 1 0 7 1 8 1
Offers in shop 2 1 13 2 15 1
Other 7 2 19 3 26 2
No fat on bread 0 0 76 11 76 7
Total 347 100 704 100 1051 100
* Amount of spread on one slice of bread estimated using a picture from a portion size picture booklet.
† Between the years 1996 and 2000.
M Simojoki et al.66
https:/www.cambridge.org/core/terms. https://doi.org/10.1079/PHN2003514
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 16:11:27, subject to the Cambridge Core terms of use, available at
Similarly, healthfulness is an important factor affecting
bread spread choice among inconsistent users. This was
reflected by the fact that two-thirds of the inconsistent
users in our study had changed their bread spread type
from plant stanol ester margarine to low-fat spread or soft
margarine. On the other hand, a variety of other factors
affect the bread spread choice of inconsistent users. In our
study, 20% of the inconsistent users regarded taste as the
main factor affecting bread spread choice, compared with
only 3% among the consistent users.
In this study, the users of plant stanol ester margarine
divided themselves into consistent and inconsistent users
according to the follow-up question: ‘What type of fat do
you usually use on bread?’ In fact, the question as such
measures current bread spread choice and does not
necessarily reveal the consistency of use, although the
question was repeated after 1 or more years. Therefore, a
validation was needed through the question on the type of
bread spread during the past 5 years. According to this
question, long-term use of plant stanol ester margarine
was indeed more pronounced among consistent users
compared with inconsistent users. This confirmed the
validity of the approach.
Four consistent users reported that they have used plant
stanol ester margarine only for 1 year. Because the time
interval between completion of the two questionnaires
ranged from 1.5 to 4.5 years, they probably used plant
stanol ester margarine by the times of the studies and
during a 1-year period between the studies. The small
number of such apparent discrepancies among the
consistent users (four out of the total of 357) further
shows that our repeated question concerning current
bread spread choice is a relatively good indicator of
long-term use.
Consistent users consumed on average 24 g of plant
stanol ester margarine daily, which is considered optimal
for lowering blood cholesterol5,7. However, one-third of
them consumed more than 25 g day21. Nearly one in four
consistent users also reported the use of other plant stanol
ester product in addition to the margarine. Health effects
of high daily amounts of plant stanol ester are not known
and need to be examined.
The follow-up study questionnaire was also sent to 3921
original non-users of plant stanol ester margarine to serve
as a reference group for our users in our forthcoming
studies. Original non-users who have become users will
then be studied separately to elucidate the factors that lead
to the use of plant stanol ester margarine.
Although the use of plant stanol ester margarine is more
often inconsistent than consistent, there is nevertheless a
relatively large subgroup of long-term users of plant stanol
ester margarine. This new information is vital when the
health effects, both beneficial and adverse, of long-term
use of plant stanol ester margarine are assessed. In future,
Table 4 Diet, body mass index and physical activity among consistent and inconsistent users of plant stanol
ester margarine
Consistent
users
Inconsistent
users Total
Consistent vs.
inconsistent users
n % n % n % x 2 P-value
Diet*
Healthy 236 70 418 61 654 64 7.9 0.005
Unhealthy 99 30 262 39 361 36
Total 335 100 680 100 1015 100
Self-perceived diet
Healthy 303 86 594 82 897 83 3.0 0.23
Average 46 13 119 16 165 15
Unhealthy 5 1 16 2 21 2
Total 354 100 729 100 1083 100
Use of alcohol†
No units 102 29 221 31 323 31 1.5 0.47
1–5 units 115 33 249 35 364 34
6 units or more 132 38 242 34 374 35
Total 349 100 712 100 1061 100
Body mass index (kg m22)‡
, 25 141 40 280 39 421 39 0.13 0.94
25–30 172 48 352 48 524 48
. 30 44 12 94 13 138 13
Total 357 100 726 100 1083 100
Leisure-time physical activity
Often 266 77 525 74 791 75 1.7 0.43
Some 58 17 143 20 201 19
Seldom 23 6 46 6 69 6
Total 347 100 714 100 1061 100
* Healthy diet includes at least three of following: daily use of vegetables, avoidance of fatty milk, use of margarine or no spread
on bread, use of bread more than 5 slices per day.
† Number of alcoholic units (120 ml wine, 40 ml spirits or one 330 ml bottle of beer, long drink or cider) during the past 7 days.
‡ Self-reported height and weight.
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we hope to address this issue by linking data from
available health registries to the cohort of users of plant
stanol ester margarine.
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